Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...

“We are pleased the FDA has accepted our NDA for Bumetanide Nasal Spray,” said Benjamin Esque, CEO of Corstasis Therapeutics Inc. “This milestone brings us closer to providing a simple, easy-to-use ...

can be repeated at 1 h intervals (max 3 mg/24 h, 6 mg/week) Migranal® nasal spray 4 mg/ml nasal spray ... 80 mg tablets 160–240 mg q.d. divided b.i.d., t.i.d. or q.i.d. Propranolol ER ...

Round the clock daily health news updates from leading and reliable sources along with RSS feeds.

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...

Thimerosal, or sodium ethylmercurithiosalicylate, is a preservative used in low concentrations mainly in vaccines, cosmetics, ophthalmic and otolaryngolic medications, antitoxins, topical and ...